I now have all the content needed for a thorough 20-mark answer. Here is the complete, structured response:
Spirometry and Lung Volumes
1. Introduction
Spirometry is the most widely used pulmonary function test. It measures the volume and flow of air that a subject can inhale and exhale, providing objective data to assess lung function in health and disease. The spirometer records these values on a calibrated tracing (spirogram), from which both static lung volumes and dynamic flow measures are derived. - Costanzo Physiology 7th Edition
2. Static Lung Volumes and Capacities
Static lung volumes are measured with a spirometer. The subject breathes into and out of the spirometer, displacing a bell, and the displaced volume is recorded. Four primary volumes and four capacities are defined. - Costanzo Physiology 7th Edition
2.1 The Four Primary Lung Volumes
| Volume | Abbreviation | Normal Value | Description |
|---|
| Tidal Volume | VT | ~500 mL | Volume of air inspired or expired in a normal, quiet breath |
| Inspiratory Reserve Volume | IRV | ~3000 mL | Extra volume that can be inspired above tidal volume with maximal effort |
| Expiratory Reserve Volume | ERV | ~1200 mL | Extra volume that can be expired below tidal volume with maximal effort |
| Residual Volume | RV | ~1200 mL | Volume remaining in the lungs after maximal forced expiration; cannot be measured by spirometry |
Key point: RV cannot be measured by a simple spirometer because it is the air that remains even after full forced expiration.
2.2 The Four Lung Capacities
Each capacity is the sum of two or more volumes:
| Capacity | Abbreviation | Formula | Normal Value | Clinical Note |
|---|
| Inspiratory Capacity | IC | VT + IRV | ~3500 mL | Measurable by spirometry |
| Functional Residual Capacity | FRC | ERV + RV | ~2400 mL | Not measurable by spirometry (contains RV) |
| Vital Capacity | VC | IC + ERV (or TLC - RV) | ~4700 mL | Measurable by spirometry |
| Total Lung Capacity | TLC | VC + RV | ~5900 mL | Not measurable by spirometry (contains RV) |
Memory aid: Capacities containing RV (FRC and TLC) cannot be measured by spirometry.
2.3 Factors Affecting Lung Volumes
- Vital capacity increases with body size, male sex, and physical conditioning
- Vital capacity decreases with age
- With aging: RV increases, FRC increases, VC decreases; TLC remains relatively stable - Fishman's Pulmonary Diseases and Disorders
3. Measurement of FRC: Special Methods
Because FRC includes RV, two indirect methods are used:
3.1 Helium Dilution Method
The subject breathes a known amount of helium (which is insoluble in blood) added to the spirometer. After several breaths, helium concentration equilibrates between lungs and spirometer. Using the conservation of helium (C1 × V1 = C2 × [V1 + FRC]), the FRC is back-calculated.
3.2 Body Plethysmography (Plethysmograph)
The subject sits in a large airtight box (plethysmograph). After expiring a normal tidal volume, the mouthpiece is closed. The subject attempts to breathe, and Boyle's Law (P × V = constant) is applied to the changes in box pressure and mouth pressure to calculate FRC. This method measures all gas in the lungs (including trapped gas), making it superior to helium dilution in patients with airway obstruction. - Costanzo Physiology 7th Edition
4. Spirometry: Dynamic Lung Function
4.1 The FVC Maneuver
The Forced Vital Capacity (FVC) is the total volume of air exhaled with maximal force from a point of maximal inhalation (TLC) to the point of maximal exhalation (RV). From the FVC maneuver, two key measures are derived: - Goldman-Cecil Medicine
- FEV1 (Forced Expiratory Volume in 1 second): the volume exhaled in the first second of the FVC maneuver. This is the most standardized single index of airflow obstruction.
- FEV1/FVC ratio: the proportion of vital capacity expelled in the first second. A ratio <70% (below the lower limit of normal) indicates obstructive lung disease.
4.2 Additional Flow Measures
| Parameter | Description | Clinical Use |
|---|
| FEF25-75% | Mean flow over the middle 50% of the FVC | Sensitive for small airway obstruction |
| PEF | Peak Expiratory Flow | Simple index; useful for monitoring asthma |
| MVV | Maximal Voluntary Ventilation (L/min) | Estimates ventilatory reserve; reduced by central obstruction or muscle weakness |
Note: FEF25-75% has poor reproducibility and many false positives/negatives, limiting its clinical utility on its own. - Murray & Nadel's Textbook of Respiratory Medicine
4.3 Bronchodilator Reversibility Testing
Spirometry is commonly performed before and after an inhaled bronchodilator (e.g., salbutamol). An improvement in FEV1 of >12% and >200 mL indicates reversible airflow obstruction, suggesting asthma rather than COPD. For testing: long-acting beta-2 agonists should be stopped for 12 hours, and short-acting bronchodilators for 6 hours before the test. - Murray & Nadel's Textbook of Respiratory Medicine
5. Spirogram and Flow-Volume Loop
5.1 Volume-Time Tracing (Spirogram)
Plots volume on the y-axis vs. time on the x-axis. FVC is the total height of the curve; FEV1 is read at the 1-second mark.
5.2 Flow-Volume Loop
Plots instantaneous flow (y-axis) vs. lung volume (x-axis) measured by a pneumotachograph. This is more sensitive for identifying the site of airway obstruction:
Flow-volume loops: Normal (right) shows a tall, symmetric expiratory curve. COPD (left) shows a small, concave (scooped) expiratory limb indicating airflow limitation. - K.J. Lee's Essential Otolaryngology
- Normal: Expiratory curve is convex (domed)
- Obstructive (COPD/asthma): Expiratory limb is concave (scooped inward), with reduced peak and mid-expiratory flows
- Restrictive: Loop is smaller but maintains normal shape; FEV1/FVC ratio is normal
- Fixed upper airway obstruction: Both inspiratory and expiratory limbs are flattened (plateau)
- Variable extrathoracic obstruction: Inspiratory limb is flattened
- Variable intrathoracic obstruction: Expiratory limb is flattened
6. Interpretation: Obstructive vs Restrictive Patterns
| Parameter | Obstructive (e.g., COPD, Asthma) | Restrictive (e.g., Fibrosis, Neuromuscular) |
|---|
| FEV1 | Decreased | Decreased |
| FVC | Normal or decreased | Decreased |
| FEV1/FVC | Decreased (<70%) | Normal or increased |
| TLC | Normal or increased | Decreased |
| RV | Increased (air trapping) | Decreased or normal |
| FRC | Increased | Decreased |
| DLCO | Decreased in emphysema; normal in asthma | Decreased in parenchymal disease |
Causes of Restrictive Pattern - Fishman's Pulmonary Diseases and Disorders
| Disease Process | Anatomic Location | Mechanism |
|---|
| Pulmonary fibrosis, ILD | Lung parenchyma | Loss/stiffening of lung tissue → reduced volumes |
| Pneumonectomy/lobectomy | Lung parenchyma | Reduced tissue → reduced volumes |
| Pleural effusion, pneumothorax, pleural thickening | Pleura, chest wall | Limited chest expansion |
| Obesity, kyphoscoliosis | Chest wall | Mechanical restriction |
| Neuromuscular disease (MND, myasthenia) | Nerves/muscles | Reduced respiratory muscle force |
Mixed Obstructive-Restrictive Pattern
Some diseases (e.g., severe sarcoidosis, interstitial fibrosis with airway involvement) produce both a low FEV1/FVC ratio and a reduced TLC, reflecting combined obstructive and restrictive physiology. - Fishman's Pulmonary Diseases and Disorders
7. Diffusing Capacity (DLCO)
DLCO measures the transfer of carbon monoxide across the alveolar-capillary membrane and reflects gas exchange efficiency:
| Severity | DLCO (% Predicted) |
|---|
| Mild reduction | >60%, but below LLN |
| Moderate reduction | 40-60% |
| Severe reduction | <40% |
- Reduced DLCO: emphysema, interstitial lung disease, pulmonary vascular disease
- Normal or elevated DLCO: asthma (due to increased upper zone perfusion)
- Fishman's Pulmonary Diseases and Disorders
8. Indications for Spirometry - Goldman-Cecil Medicine
- Diagnosis and characterization of respiratory symptoms (dyspnoea, chronic cough, wheeze)
- Monitoring response to therapy (bronchodilators, corticosteroids)
- Objective quantification of physiologic impairment
- Preoperative risk assessment
- Disability evaluation and occupational health screening
- Monitoring drug toxicity (e.g., amiodarone, bleomycin)
9. Normal Values (Summary Table) - Costanzo Physiology 7th Edition
| Parameter | Approximate Normal Value |
|---|
| Tidal Volume (VT) | 500 mL |
| IRV | 3000 mL |
| ERV | 1200 mL |
| RV | 1200 mL |
| IC | 3500 mL |
| FRC | 2400 mL |
| VC | 4700 mL |
| TLC | 5900 mL |
| FEV1/FVC | ≥70% |
10. Key Clinical Points
- RV, FRC, and TLC cannot be measured by standard spirometry - they require helium dilution or body plethysmography
- Body plethysmography is preferred over helium dilution in obstructive diseases because trapped gas is included in the measurement
- FEV1 is the single most useful and standardized index of airflow obstruction
- A reversible fall in FEV1 (>12% + 200 mL) after bronchodilator favors asthma; a fixed fall favors COPD
- The flow-volume loop provides additional diagnostic information, especially for upper airway obstruction, beyond what volume-time spirograms can show
- Aging increases RV and FRC, decreases VC, while TLC changes minimally